Mitotane induces CYP3A4 expression via activation of the steroid and xenobiotic receptor
Authors:
- Akira TakeshitaATAkira Takeshita
- Noriyuki KoibuchiNKNoriyuki Koibuchi
- Yasuhiro TakeuchiYTYasuhiro Takeuchi
- 22 November 2012
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 216 (3) , 297-305
Abstract
Adrenocortical carcinoma (ACC) is a rare disease with an extremely poor prognosis. Mitotane alone or in combination with other cytotoxic drugs is a common therapeutic option for ACC. In addition to its adrenolytic function, mitotane has been known for decades to increase the metabolic clearance of glucocorticoids. It was recently shown that the tyrosine kinase inhibitor sunitinib is also rapidly metabolized in patients treated with mitotane, indicating that mitotane engages in clinically relevant drug interactions. Although the precise mechanism of these interactions is not well understood, cytochrome P450 mono-oxygenase 3A4 (CYP3A4) is a key enzyme to inactivate both glucocorticoids and sunitinib. The nuclear receptor steroid and xenobiotic receptor (SXR (NR1I2)) is one of the key transcriptional regulators ofCYP3A4gene expression in the liver and intestine. A variety of xenobiotics bind to SXR and stimulate transcription of xenobiotic-response elements (XREs) located in theCYP3A4gene promoter. In this study, we evaluated the effects of mitotane on SXR-mediated transcriptionin vitroby luciferase reporter analysis, SXR–steroid receptor coactivator 1 (SRC1) interactions, quantitative real-time PCR analysis ofCYP3A4expression, SXR knockdown, and CYP3A4 enzyme activity assays using human hepatocyte-derived cells. We found that mitotane activated SXR-mediated transcription of the XREs. Mitotane recruited SRC1 to the ligand-binding domain of SXR. Mitotane increasedCYP3A4mRNA levels, which was attenuated by SXR knockdown. Finally, we showed that mitotane increased CYP3A4 enzyme activity. We conclude that mitotane can induceCYP3A4gene expression and suggest that mitotane is used cautiously due to its drug–drug interactions.Keywords
This publication has 25 references indexed in Scilit:
- Mitotane has a strong and a durable inducing effect on CYP3A4 activityEuropean Journal of Endocrinology, 2011
- Pregnane X Receptor and Constitutive Androstane Receptor at the Crossroads of Drug Metabolism and Energy MetabolismDrug Metabolism and Disposition, 2010
- Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CARAdvanced Drug Delivery Reviews, 2010
- PXR: A Xenobiotic Receptor of Diverse Function Implicated in PharmacogeneticsPharmacogenomics, 2008
- Pregnane X Receptor-Dependent Induction of the CYP3A4 Gene by o,p′-1,1,1,-Trichloro-2,2-Bis (p-Chlorophenyl)ethaneDrug Metabolism and Disposition, 2007
- The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cellsJournal of Endocrinology, 2006
- Adrenocortical Carcinoma: Clinical UpdateThe Journal of Clinical Endocrinology & Metabolism, 2006
- Transcriptional induction of CYP3A4 by o,p′-DDT in HepG2 cellsToxicology Letters, 2005
- THE EFFECT OF o,p'‐DDD ON ADRENAL STEROID REPLACEMENT THERAPY REQUIREMENTSClinical Endocrinology, 1987
- Influence of Mitotane on the Hypoprothrombinemic Effect of WarfarinSouthern Medical Journal, 1986